Article Versions Notes

Lee DH, Park K-S, Shin HE, Kim SB, Choi H, An SB, Choi H, Kim JP, Han I. Safety and Feasibility of Intradiscal Administration of Matrilin-3-Primed Adipose-Derived Mesenchymal Stromal Cell Spheroids for Chronic Discogenic Low Back Pain: Phase 1 Clinical Trial. International Journal of Molecular Sciences. 2023; 24(23):16827. https://doi.org/10.3390/ijms242316827

Lee, Dong Hyun, Kwang-Sook Park, Hae Eun Shin, Sung Bum Kim, Hyejeong Choi, Seong Bae An, Hyemin Choi, Joo Pyung Kim, and Inbo Han. 2023. "Safety and Feasibility of Intradiscal Administration of Matrilin-3-Primed Adipose-Derived Mesenchymal Stromal Cell Spheroids for Chronic Discogenic Low Back Pain: Phase 1 Clinical Trial" International Journal of Molecular Sciences 24, no. 23: 16827. https://doi.org/10.3390/ijms242316827

Lee, D. H., Park, K. -S., Shin, H. E., Kim, S. B., Choi, H., An, S. B., Choi, H., Kim, J. P., & Han, I. (2023). Safety and Feasibility of Intradiscal Administration of Matrilin-3-Primed Adipose-Derived Mesenchymal Stromal Cell Spheroids for Chronic Discogenic Low Back Pain: Phase 1 Clinical Trial. International Journal of Molecular Sciences, 24(23), 16827. https://doi.org/10.3390/ijms242316827